Tecovirimat’s Efficacy in Mpox Treatment: An In-Depth Analysis

Tecovirimat’s Efficacy in Mpox Treatment: An In-Depth Analysis The National Institutes of Health (NIH) recently published findings from an international clinical trial known as STOMP, which investigated the efficacy of Tecovirimat, a drug developed by SIGA Technologies, in treating mpox, specifically the clade II strain. This study was particularly significant as it marked one of […]